ReviewJournal of the American Heart Association2020

Molecular, Cellular, and Clinical Evidence That Sodium-Glucose Cotransporter 2 Inhibitors Act as Neurohormonal Antagonists When Used for the Treatment of Chronic Heart Failure.

Milton PackerPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.